Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes

British Journal of Pharmacology
K M Coates, P Flood

Abstract

1. Ketamine is a dissociative anaesthetic that is formulated as Ketalar, which contains the preservative benzethonium chloride (BCl). We have studied the effects of pure racemic ketamine, the preservative BCl and the Ketalar mixture on human neuronal nicotinic acetylcholine receptors (nAChRs) composed of the alpha7 subunit or alpha4 and beta2 subunits expressed in Xenopus laevis oocytes. 2. Ketamine inhibited responses to 1 mM acetylcholine (ACh) in both the human alpha7 and alpha4beta2 nAChRs, with IC(50) values of 20 and 50 microM respectively. Inhibition of the alpha7 nAChRs occurred within a clinically relevant concentration range, while inhibition of the alpha4beta2 nAChR was observed only at higher concentrations. The Ketalar formulation inhibited nAChR function more effectively than was expected given its ketamine concentration. The surprising increased inhibitory potency of Ketalar compared with pure ketamine appeared to be due to the activity of BCl, which inhibited both alpha7 (IC(50) value of 122 nM) and alpha4beta2 (IC(50) value of 49 nM) nAChRs at concentrations present in the clinical formulation of Ketalar. 3. Ketamine is a noncompetitive inhibitor at both the alpha7 and alpha4beta2 nAChR. In contrast, BCl causes...Continue Reading

References

Dec 1, 1979·British Journal of Anaesthesia·J IdvallP Stenberg
Feb 1, 1985·British Journal of Pharmacology·N L Harrison, M A Simmonds
May 15, 1972·American Journal of Obstetrics and Gynecology·B LittleA Y Sweet
Jul 1, 1995·Anesthesia and Analgesia·M E Durieux
Apr 1, 1997·Anesthesiology·B A OrserJ F MacDonald
Aug 1, 1997·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·Z ZamanK Desmet
Apr 26, 2000·Anesthesiology·P Flood, M D Krasowski

❮ Previous
Next ❯

Citations

May 1, 2007·European Journal of Clinical Pharmacology·Helena BrandinGunilla Brenning
May 15, 2013·Pharmacology, Biochemistry, and Behavior·Shawn E KotermanskiEdda Thiels
Dec 20, 2007·Critical Care Medicine·Stefan HoferMarkus A Weigand
Jul 12, 2008·International Anesthesiology Clinics·Stuart A Forman, Victor A Chin
Jul 12, 2008·International Anesthesiology Clinics·Christa J Van DortRalph Lydic
Jun 5, 2007·Clinical Neuropharmacology·James M Ferguson, Richard N Shingleton
Feb 7, 2009·Critical Care : the Official Journal of the Critical Care Forum·Stefan HoferMarkus A Weigand
Sep 19, 2009·Anesthesia and Analgesia·Steven L JinksJoseph F Antognini
Feb 4, 2006·American Journal of Veterinary Research·Alonso G P GuedesElaine P Rudé
Apr 29, 2014·Medical Hypotheses·Mehmet AksoyHalis Suleyman
May 6, 2009·Basic & Clinical Pharmacology & Toxicology·Hui-Ru HsuHwei-Hsien Chen
Feb 6, 2008·Journal of Neurochemistry·Xiomara A PerezMaryka Quik
Mar 8, 2006·The International Journal of Biochemistry & Cell Biology·Hugo R AriasCecilia Bouzat
Jul 4, 2015·British Journal of Pharmacology·Nagendra S SinghIrving W Wainer
Apr 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·Radovan SpurnyChris Ulens
Sep 16, 2009·Biophysical Journal·Richard J Law, Felice C Lightstone
Dec 13, 2012·Expert Opinion on Therapeutic Targets·Tanya L Wallace, Daniel Bertrand
Aug 24, 2016·Expert Opinion on Drug Discovery·Miguel Reyes-Parada, Patricio Iturriaga-Vasquez
Apr 19, 2017·ACS Chemical Neuroscience·Marshall W TylerStephen J Haggarty
Apr 20, 2002·Anesthesiology·Pamela Flood, Kristen M Coates
Jun 28, 2005·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Fereshteh ChekinNaader Alizadeh
Nov 25, 2003·Anesthesia and Analgesia·Graham Hocking, Michael J Cousins
Nov 9, 2006·International Journal of Toxicology
Nov 19, 2002·Journal of Neurobiology·Edna F R PereiraEdson X Albuquerque
Jul 11, 2007·Current Opinion in Anaesthesiology·Ken Solt, Stuart A Forman
Dec 12, 2007·Alcoholism, Clinical and Experimental Research·Amanda C Sharko, Clyde W Hodge
Sep 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthew T AvilaGunvant K Thaker
Jun 28, 2018·Pharmacological Reviews·Panos ZanosTodd D Gould
Sep 10, 2004·The Journal of Pharmacology and Experimental Therapeutics·M I DamajB R Martin
Jul 23, 2005·Anesthesia and Analgesia·Julia O UdeskyPamela Flood
Oct 5, 2006·Current Opinion in Anaesthesiology·Beverley A OrserJohn F Macdonald
Jun 27, 2019·Journal of Neurophysiology·Fahad IqbalNaweed I Syed

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.